CD40LG and COVID-19: We also found C1q deposition in some COVID-19 patients’ lymphocytes, which together with the observed in vitro IgM-mediated complement activity, suggests that activation of the classical complement pathway, presumably by IgM ALAb, might also play a role in vivo.